CLPX_HUMAN - dbPTM
CLPX_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CLPX_HUMAN
UniProt AC O76031
Protein Name ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial
Gene Name CLPX
Organism Homo sapiens (Human).
Sequence Length 633
Subcellular Localization Mitochondrion. Mitochondrion matrix, mitochondrion nucleoid.
Protein Description ATP-dependent specificity component of the Clp protease complex. Hydrolyzes ATP. Targets specific substrates for degradation by the Clp complex. [PubMed: 11923310]
Protein Sequence MPSCGACTCGAAAVRLITSSLASAQRGISGGRIHMSVLGRLGTFETQILQRAPLRSFTETPAYFASKDGISKDGSGDGNKKSASEGSSKKSGSGNSGKGGNQLRCPKCGDLCTHVETFVSSTRFVKCEKCHHFFVVLSEADSKKSIIKEPESAAEAVKLAFQQKPPPPPKKIYNYLDKYVVGQSFAKKVLSVAVYNHYKRIYNNIPANLRQQAEVEKQTSLTPRELEIRRREDEYRFTKLLQIAGISPHGNALGASMQQQVNQQIPQEKRGGEVLDSSHDDIKLEKSNILLLGPTGSGKTLLAQTLAKCLDVPFAICDCTTLTQAGYVGEDIESVIAKLLQDANYNVEKAQQGIVFLDEVDKIGSVPGIHQLRDVGGEGVQQGLLKLLEGTIVNVPEKNSRKLRGETVQVDTTNILFVASGAFNGLDRIISRRKNEKYLGFGTPSNLGKGRRAAAAADLANRSGESNTHQDIEEKDRLLRHVEARDLIEFGMIPEFVGRLPVVVPLHSLDEKTLVQILTEPRNAVIPQYQALFSMDKCELNVTEDALKAIARLALERKTGARGLRSIMEKLLLEPMFEVPNSDIVCVEVDKEVVEGKKEPGYIRAPTKESSEEEYDSGVEEEGWPRQADAANS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
29PhosphorylationASAQRGISGGRIHMS
HHHHHCCCCCCCCHH
37.7124719451
36PhosphorylationSGGRIHMSVLGRLGT
CCCCCCHHHHCCCCC
10.4624719451
43PhosphorylationSVLGRLGTFETQILQ
HHHCCCCCHHHHHHH
23.9224719451
66PhosphorylationETPAYFASKDGISKD
CCCCEECCCCCCCCC
22.75-
67UbiquitinationTPAYFASKDGISKDG
CCCEECCCCCCCCCC
57.45-
71PhosphorylationFASKDGISKDGSGDG
ECCCCCCCCCCCCCC
30.17-
80UbiquitinationDGSGDGNKKSASEGS
CCCCCCCCCCCCCCC
54.34-
81UbiquitinationGSGDGNKKSASEGSS
CCCCCCCCCCCCCCC
56.08-
89UbiquitinationSASEGSSKKSGSGNS
CCCCCCCCCCCCCCC
53.29-
90UbiquitinationASEGSSKKSGSGNSG
CCCCCCCCCCCCCCC
63.10-
98AcetylationSGSGNSGKGGNQLRC
CCCCCCCCCCCCEEC
64.5620167786
145PhosphorylationSEADSKKSIIKEPES
EHHHHCCCCCCCHHH
33.0324719451
152O-linked_GlycosylationSIIKEPESAAEAVKL
CCCCCHHHHHHHHHH
43.4230379171
178AcetylationKIYNYLDKYVVGQSF
HHHHHHHHHHHCHHH
37.0319608861
179PhosphorylationIYNYLDKYVVGQSFA
HHHHHHHHHHCHHHH
10.4728258704
187MethylationVVGQSFAKKVLSVAV
HHCHHHHHHHHHHHH
41.21-
1872-HydroxyisobutyrylationVVGQSFAKKVLSVAV
HHCHHHHHHHHHHHH
41.21-
217UbiquitinationRQQAEVEKQTSLTPR
HHHHHHHHHCCCCHH
65.14-
220PhosphorylationAEVEKQTSLTPRELE
HHHHHHCCCCHHHHH
27.9623403867
222PhosphorylationVEKQTSLTPRELEIR
HHHHCCCCHHHHHHH
21.77-
239UbiquitinationEDEYRFTKLLQIAGI
HHHHHHHHHHHHCCC
44.48-
269UbiquitinationNQQIPQEKRGGEVLD
HHHCCHHHCCCCCCC
51.61-
270MethylationQQIPQEKRGGEVLDS
HHCCHHHCCCCCCCC
58.56-
277PhosphorylationRGGEVLDSSHDDIKL
CCCCCCCCCCCCCEE
25.9726471730
278PhosphorylationGGEVLDSSHDDIKLE
CCCCCCCCCCCCEEC
30.5126471730
286UbiquitinationHDDIKLEKSNILLLG
CCCCEECCCCEEEEC
60.27-
2862-HydroxyisobutyrylationHDDIKLEKSNILLLG
CCCCEECCCCEEEEC
60.27-
287PhosphorylationDDIKLEKSNILLLGP
CCCEECCCCEEEECC
21.5220068231
295PhosphorylationNILLLGPTGSGKTLL
CEEEECCCCCCHHHH
42.0320068231
297PhosphorylationLLLGPTGSGKTLLAQ
EEECCCCCCHHHHHH
39.3320068231
299UbiquitinationLGPTGSGKTLLAQTL
ECCCCCCHHHHHHHH
37.38-
300PhosphorylationGPTGSGKTLLAQTLA
CCCCCCHHHHHHHHH
30.45-
349UbiquitinationDANYNVEKAQQGIVF
HCCCCHHHHHCCEEE
47.41-
362UbiquitinationVFLDEVDKIGSVPGI
EEEECCCCCCCCCCC
54.89-
373MethylationVPGIHQLRDVGGEGV
CCCCEECCCCCCHHH
29.96-
386UbiquitinationGVQQGLLKLLEGTIV
HHHHHHHHHHCCCEE
56.95-
398UbiquitinationTIVNVPEKNSRKLRG
CEEECCCCCCCHHCC
54.90-
398AcetylationTIVNVPEKNSRKLRG
CEEECCCCCCCHHCC
54.9025953088
407PhosphorylationSRKLRGETVQVDTTN
CCHHCCCEEEECCCC
21.0429978859
412PhosphorylationGETVQVDTTNILFVA
CCEEEECCCCEEEEE
23.9228258704
413PhosphorylationETVQVDTTNILFVAS
CEEEECCCCEEEEEC
18.7928258704
420PhosphorylationTNILFVASGAFNGLD
CCEEEEECCHHCCHH
25.9229978859
437AcetylationISRRKNEKYLGFGTP
HHHCCCCCCCCCCCC
55.9919608861
437UbiquitinationISRRKNEKYLGFGTP
HHHCCCCCCCCCCCC
55.9919608861
438PhosphorylationSRRKNEKYLGFGTPS
HHCCCCCCCCCCCCC
13.0923684312
443PhosphorylationEKYLGFGTPSNLGKG
CCCCCCCCCCCCCCH
22.6816964243
445PhosphorylationYLGFGTPSNLGKGRR
CCCCCCCCCCCCHHH
44.5229396449
449MalonylationGTPSNLGKGRRAAAA
CCCCCCCCHHHHHHH
53.0326320211
449UbiquitinationGTPSNLGKGRRAAAA
CCCCCCCCHHHHHHH
53.03-
475AcetylationTHQDIEEKDRLLRHV
CCCCHHHHHHHHHHH
35.0423749302
512UbiquitinationPLHSLDEKTLVQILT
ECCCCCCCHHHHHHH
46.99-
529PhosphorylationRNAVIPQYQALFSMD
CCCCCHHHHHHHCCC
7.1522817900
548UbiquitinationNVTEDALKAIARLAL
CCCHHHHHHHHHHHH
39.19-
591AcetylationIVCVEVDKEVVEGKK
EEEEEECHHHHCCCC
58.5519828841
597AcetylationDKEVVEGKKEPGYIR
CHHHHCCCCCCCCCC
40.2219828849
607PhosphorylationPGYIRAPTKESSEEE
CCCCCCCCCCCCHHH
46.5928450419
610PhosphorylationIRAPTKESSEEEYDS
CCCCCCCCCHHHHHC
44.6023927012
611PhosphorylationRAPTKESSEEEYDSG
CCCCCCCCHHHHHCC
50.5525159151
615PhosphorylationKESSEEEYDSGVEEE
CCCCHHHHHCCCCCC
20.7730576142
617PhosphorylationSSEEEYDSGVEEEGW
CCHHHHHCCCCCCCC
43.7828355574
633PhosphorylationRQADAANS-------
CCHHHCCC-------
36.5521406692

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CLPX_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CLPX_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CLPX_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CLPP_HUMANCLPPphysical
11923310
CH10_HUMANHSPE1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CLPX_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-178 AND LYS-437, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-617, AND MASSSPECTROMETRY.

TOP